StonvexLoading…
StonvexStonvexStonvexCore line items from ST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $934.80M | $3.70B | $2.79B | $1.85B |
Operating Income | $141.60M | $237.50M | $137.37M | $260.26M |
Net Income | $87.10M | $31.30M | $-31.94M | $130.59M |
EPS (Diluted) | $0.59 | $0.21 | $-0.22 | $0.88 |
Total Assets | $6.82B | $6.75B | $7.07B | $7.27B |
Total Liabilities | $3.96B | $3.97B | $4.35B | $4.39B |
Cash & Equivalents | $635.10M | $573.00M | $791.35M | $661.78M |
Free Cash Flow OCF − CapEx | $104.60M | $490.30M | $338.38M | $202.14M |
Shares Outstanding | 146.60M | 147.10M | 146.79M | 147.66M |